NCT00750620 2013-09-05A Pharmacokinetic Study of YM178 in Normal Subjects and Those With Mild, Moderate, and Severe Renal ImpairmentAstellas Pharma IncPhase 1 Completed33 enrolled
NCT01579461 2013-09-05A Study to Investigate the Effect of Mirabegron (YM178) on Subjects With Mild or Moderate Hepatic Impairment Compared to Healthy SubjectsAstellas Pharma IncPhase 1 Completed32 enrolled